Loading clinical trials...
Loading clinical trials...
Cytomegalovirus (CMV) is a common virus that infects many people. It can cause serious illness in people with weak immune systems especially in those undergoing transplants. LIVTENCITY (Maribavir) is ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Takeda
NCT06439342 · Cytomegalovirus (CMV)
NCT07014319 · Cytomegalovirus (CMV)
NCT06793124 · Cytomegalovirus (CMV), Inflammatory Bowel Disease (IBD)
NCT07488481 · Cytomegalovirus (CMV) Infection, Kidney Transplant Recipient
NCT06615921 · Cytomegalovirus (CMV)
The Catholic University of Korea, Seoul ST. Mary's Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions